光量子血氧疗法治疗急性呼吸窘迫综合征的临床疗效观察

目的：研究用光量子血氧疗法治疗急性呼吸窘迫综合征（ＡＲＤＳ）的临床疗效。方法：早期ＡＲＤＳ患者６０例，随机分为对照组（３０例）、治疗组（３０例），对照组采用常规综合治疗，治疗组在综合治疗的基础上加用光量子血氧疗法。观察２组血液流变性、肺动脉压（ＰＡＰ）、氧合指数（ＰａＯ２／ＦｉＯ２）和红细胞Ｃ３ｂ受体花环率（ＲＣ３ｂＲＲ）及其免疫复合物花环率（ＲＩＣＲ）的变化和治愈率。结果：治疗组较对照组血液流变

Photonhemoxytherapy for the treatment of acute respiratory distress syndrome

Objective:To explore clinical effects of photonhemoxytherapy for the treatment of acute respiratory distress syndrome(ARDS).Methods:Sixty patients with ARDS in early stage were randomly divided into two groups:control group (n=30) and photonhemoxytherapy treatment group (n=30).The control group was given conventional therapy and in the treatment group photonhemoxytherapy was added to the conventional therapy.Results:Compared with the control group,the pulmonary arterial pressure(PAP) and the values of PaO 2/FiO 2,red blood cellC 3b receptor ratio(RC 3bRR) and red blood cellimmune complex ratio(RICR) were remarkably changed in the treatment group (P<0 05 or P<0 01).The cure rate of treatment group was 83 3% and control group was 56 7%(P<0 05).Conclusions:In patients with ARDS photonhemoxytherapy can rapidly improve the hemorrheology,raise the value of PaO 2/FiO 2,improve the oxygenation of the lung,enhance the immune function.